View Older Stories

Jun 1, 2026 08:28AM TD Cowen Reiterates Buy Rating and Top Pick on Revolution (RVMD)

Jun 1, 2026 07:36AM Revolution (RVMD) Reiterated at Buy by Stifel

May 21, 2026 04:38PM Bernstein SocGen Group Starts Revolution (RVMD) at Market Perform

May 21, 2026 04:13PM Revolution Medicines schedules call on pancreatic cancer trial results

May 18, 2026 06:21AM Truist Securities Assumes Revolution (RVMD) at Buy

May 7, 2026 07:55AM Revolution (RVMD) PT Lowered to $183 at Needham

May 6, 2026 04:05PM Revolution Medicines, Inc. (RVMD) Misses Q1 EPS by 46c, provides guidance

May 1, 2026 12:54PM Revolution Medicines receives FDA early access authorization for pancreatic cancer pill

Apr 28, 2026 10:57AM TD Cowen Reiterates Buy Rating on Revolution (RVMD)

Apr 23, 2026 04:35AM Revolution (RVMD) PT Raised to $185 at Mizuho

Apr 20, 2026 07:13AM Revolution (RVMD) PT Raised to $186 at Needham

Apr 20, 2026 06:03AM Revolution (RVMD) PT Raised to $215 at Stifel

Apr 17, 2026 04:02PM Revolution Medicines closes $2.2 billion dual public offerings

Apr 14, 2026 06:46AM Revolution (RVMD) PT Raised to $169 at H.C. Wainwright

Apr 14, 2026 06:41AM Mizuho Reiterates Outperform Rating on Revolution (RVMD)

Apr 14, 2026 06:39AM Revolution (RVMD) PT Raised to $162 at RBC Capital

Apr 14, 2026 05:24AM Revolution (RVMD) PT Raised to $200 at Evercore ISI

Apr 13, 2026 11:28AM Revolution (RVMD) PT Raised to $165 at Oppenheimer

Apr 13, 2026 10:59AM Revolution (RVMD) PT Raised to $170 at BofA Securities Amid 36% Gain

Apr 13, 2026 10:37AM Revolution (RVMD) PT Raised to $147 at Leerink Partners

Apr 13, 2026 10:24AM Revolution (RVMD) PT Raised to $175 at Raymond James

Apr 13, 2026 10:16AM Increasing unusual call option volume: ALLO CORN CNK ALMU ADMA JBL SPIR OGN REPL ORBS LWLG CANE RVMD

Apr 9, 2026 06:37AM Mizuho Reiterates Outperform Rating on Revolution (RVMD)

Apr 7, 2026 07:52AM Revolution (RVMD) Reiterated at Buy by Stifel Ahead of Numerous Stock-Moving Events

Mar 23, 2026 04:53AM Revolution Medicines (RVMD) call put ratio 1 call to 4.7 puts with a focus on April 70 and 90 puts

Mar 22, 2026 10:00AM Jefferies says these are the best SMID-cap biotech stocks to buy

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Feb 27, 2026 01:07AM UBS Assumes Revolution (RVMD) at Buy

Feb 26, 2026 01:25PM Stifel Earlier Defended Tango Therapeutics Inc. (TNGX) Amid 12pct Decline

Feb 26, 2026 07:20AM Revolution (RVMD) PT Raised to $120 at Piper Sandler

Feb 26, 2026 07:14AM Revolution (RVMD) PT Lowered to $145 at Needham

Feb 26, 2026 06:00AM Revolution (RVMD) PT Raised to $144 at Wells Fargo

Feb 25, 2026 04:04PM Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Feb 9, 2026 03:45PM Revolution Medicines (RVMD) spreader of April 80, June 50 and June 80 puts

Jan 27, 2026 05:56AM Revolution (RVMD) PT Raised to $150 at Oppenheimer

Jan 26, 2026 08:59AM Truist Securities keeps Revolution (RVMD) at Buy, 'believe that RVMD is well funded and doesn't need to do a deal'

Jan 26, 2026 08:43AM Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit

Jan 25, 2026 02:35PM Merck ends acquisition talks with Revolution Medicines - WSJ

Jan 22, 2026 08:32AM Revolution (RVMD) PT Raised to $170 at Stifel as Pipeline Has Unrecognized Value

Jan 21, 2026 09:06AM Revolution (RVMD) PT Raised to $140 at RBC Capital

Jan 20, 2026 06:54AM Revolution (RVMD) PT Raised to $160 at Guggenheim

Jan 13, 2026 09:07AM Goldman Sachs on Revolution (RVMD): 'Catalyst-rich 2026 underpins the breadth of the clinical portfolio'

Jan 12, 2026 03:23PM RStifel on evolution Medicines (RVMD): 'RVMD's Hand is Looking Stronger Than Ever!'

Jan 12, 2026 09:34AM Truist Securities Reiterates Buy Rating on Revolution (RVMD)

Jan 9, 2026 03:55PM STAT reported Feuerstein: meeting with Revolution Medicines CEO cancelled

Jan 9, 2026 03:02PM Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

Jan 9, 2026 02:44PM Revolution Medicines (RVMD) CEO Said to Cancel Upcoming Meetings Amid M&A Chatter

Jan 9, 2026 04:57AM Revolution (RVMD) PT Raised to $109 at BofA Securities

Jan 8, 2026 04:46PM After-hours movers: Rocket Companies, General Motors, Intel, and more

Jan 8, 2026 04:34PM Merck Discussed $28B-$32B Price For Revolution Medicines - FT

View Older Stories